Lineage Cell Therapeutics (LCTX)
(Delayed Data from AMEX)
$1.17 USD
-0.01 (-0.85%)
Updated May 10, 2024 04:00 PM ET
After-Market: $1.18 +0.01 (0.85%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-0.04 | 0.00% |
Earnings Summary
For their last quarter, Lineage Cell Therapeutics (LCTX) reported earnings of -$0.04 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for LCTX's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$0.04 per share, reflecting a year-over-year decrease of 33.33%.
Earnings History
Price & Consensus
Zacks News for LCTX
Lineage Cell (LCTX) Reports Q2 Loss, Tops Revenue Estimates
LCTX: What are Zacks experts saying now?
Zacks Private Portfolio Services